Bruker Total Current Liabilities 2010-2025 | BRKR
Bruker total current liabilities from 2010 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
- Bruker total current liabilities for the quarter ending March 31, 2025 were $1.345B, a 13.73% increase year-over-year.
- Bruker total current liabilities for 2024 were $1.281B, a 6.59% increase from 2023.
- Bruker total current liabilities for 2023 were $1.202B, a 31.48% increase from 2022.
- Bruker total current liabilities for 2022 were $0.914B, a 2.58% decline from 2021.
Bruker Annual Total Current Liabilities
(Millions of US $) |
| 2024 |
$1,281 |
| 2023 |
$1,202 |
| 2022 |
$914 |
| 2021 |
$939 |
| 2020 |
$792 |
| 2019 |
$646 |
| 2018 |
$599 |
| 2017 |
$525 |
| 2016 |
$525 |
| 2015 |
$555 |
| 2014 |
$583 |
| 2013 |
$649 |
| 2012 |
$682 |
| 2011 |
$756 |
| 2010 |
$832 |
| 2009 |
$541 |
Bruker Quarterly Total Current Liabilities
(Millions of US $) |
| 2025-03-31 |
$1,345 |
| 2024-12-31 |
$1,281 |
| 2024-09-30 |
$1,322 |
| 2024-06-30 |
$1,305 |
| 2024-03-31 |
$1,183 |
| 2023-12-31 |
$1,202 |
| 2023-09-30 |
$1,072 |
| 2023-06-30 |
$1,051 |
| 2023-03-31 |
$1,049 |
| 2022-12-31 |
$914 |
| 2022-09-30 |
$865 |
| 2022-06-30 |
$818 |
| 2022-03-31 |
$881 |
| 2021-12-31 |
$939 |
| 2021-09-30 |
$921 |
| 2021-06-30 |
$955 |
| 2021-03-31 |
$944 |
| 2020-12-31 |
$792 |
| 2020-09-30 |
$683 |
| 2020-06-30 |
$750 |
| 2020-03-31 |
$766 |
| 2019-12-31 |
$646 |
| 2019-09-30 |
$643 |
| 2019-06-30 |
$641 |
| 2019-03-31 |
$633 |
| 2018-12-31 |
$599 |
| 2018-09-30 |
$563 |
| 2018-06-30 |
$532 |
| 2018-03-31 |
$559 |
| 2017-12-31 |
$525 |
| 2017-09-30 |
$514 |
| 2017-06-30 |
$494 |
| 2017-03-31 |
$515 |
| 2016-12-31 |
$525 |
| 2016-09-30 |
$553 |
| 2016-06-30 |
$535 |
| 2016-03-31 |
$542 |
| 2015-12-31 |
$555 |
| 2015-09-30 |
$676 |
| 2015-06-30 |
$652 |
| 2015-03-31 |
$541 |
| 2014-12-31 |
$583 |
| 2014-09-30 |
$610 |
| 2014-06-30 |
$629 |
| 2014-03-31 |
$671 |
| 2013-12-31 |
$649 |
| 2013-09-30 |
$647 |
| 2013-06-30 |
$603 |
| 2013-03-31 |
$643 |
| 2012-12-31 |
$682 |
| 2012-09-30 |
$687 |
| 2012-06-30 |
$752 |
| 2012-03-31 |
$772 |
| 2011-12-31 |
$756 |
| 2011-09-30 |
$920 |
| 2011-06-30 |
$902 |
| 2011-03-31 |
$871 |
| 2010-12-31 |
$832 |
| 2010-09-30 |
$592 |
| 2010-06-30 |
$543 |
| 2010-03-31 |
$544 |
| 2009-12-31 |
$541 |
| 2009-09-30 |
$521 |
| 2009-06-30 |
$519 |
| 2009-03-31 |
$492 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$6.334B |
$3.366B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
